Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
18.39
-0.18 (-0.97%)
Mar 6, 2026, 9:35 AM EST - Market open
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Alignment Healthcare stock have an average target of 23, with a low estimate of 18 and a high estimate of 30. The average target predicts an increase of 25.07% from the current stock price of 18.39.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Alignment Healthcare stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 4 | 4 | 3 |
| Buy | 4 | 5 | 6 | 6 | 6 | 5 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 12 | 12 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $23 → $26 | Buy | Maintains | $23 → $26 | +41.38% | Feb 5, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $19 → $25 | Strong Buy | Maintains | $19 → $25 | +35.94% | Jan 16, 2026 |
| UBS | UBS | Hold Maintains $18 → $21 | Hold | Maintains | $18 → $21 | +14.19% | Jan 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 → $30 | Buy | Maintains | $20 → $30 | +63.13% | Jan 6, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $20 → $23 | Buy | Maintains | $20 → $23 | +25.07% | Dec 17, 2025 |
Financial Forecast
Revenue This Year
5.34B
from 3.95B
Increased by 35.26%
Revenue Next Year
6.68B
from 5.34B
Increased by 25.00%
EPS This Year
0.12
from -0.00
EPS Next Year
0.72
from 0.12
Increased by 477.40%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.8B | 7.3B | |||
| Avg | 5.3B | 6.7B | |||
| Low | 5.0B | 6.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 47.1% | 36.2% | |||
| Avg | 35.3% | 25.0% | |||
| Low | 27.8% | 12.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.17 | 0.81 | |
| Avg | 0.12 | 0.72 | |
| Low | 0.05 | 0.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 549.2% | |
| Avg | - | 477.4% | |
| Low | - | 419.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.